• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Different manifestations of patients with inhibitors against prothrombin and thrombin.

作者信息

Tang Ning, Li Dengju

机构信息

Department of Clinical Laboratory, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095, Jiefang Avenue, Wuhan City, Hubei Province, China.

出版信息

J Thromb Thrombolysis. 2020 Jan;49(1):164-167. doi: 10.1007/s11239-019-01948-0.

DOI:10.1007/s11239-019-01948-0
PMID:31549352
Abstract
摘要

相似文献

1
Different manifestations of patients with inhibitors against prothrombin and thrombin.
J Thromb Thrombolysis. 2020 Jan;49(1):164-167. doi: 10.1007/s11239-019-01948-0.
2
Prothrombin Marburg--a dysfunctional coagulation protein.凝血酶原马尔堡——一种功能失调的凝血蛋白。
Thromb Res. 1997 Nov 1;88(3):337-42. doi: 10.1016/s0049-3848(97)00259-4.
3
Prothrombal: a new concentrate of human prothrombin complex for clinical use.凝血酶原复合物：一种供临床使用的新型人凝血酶原复合物浓缩剂。
Br J Haematol. 1971 Oct;21(4):377-98. doi: 10.1111/j.1365-2141.1971.tb02699.x.
4
The use of rituximab therapy in patients with acquired factor V inhibitors.利妥昔单抗疗法在获得性因子V抑制剂患者中的应用。
Am J Hematol. 2012 Aug;87(8):826-7. doi: 10.1002/ajh.23241. Epub 2012 May 28.
5
Acquired Factor V Inhibitor with Symptoms and Titer of Inhibitor Differences: Report of Two Cases.具有抑制剂症状及滴度差异的获得性因子V抑制剂：两例报告
Acta Haematol. 2019;141(3):148-150. doi: 10.1159/000496080. Epub 2019 Feb 15.
6
Catastrophic haemorrhage in a case of paediatric primary antiphospholipid syndrome and factor II deficiency.小儿原发性抗磷脂综合征合并凝血因子Ⅱ缺乏症患者的灾难性出血
Lupus. 1997;6(1):68-71. doi: 10.1177/096120339700600110.
7
A new variant of human prothrombin: prothrombin Metz, demonstration in a family showing double heterozygosity for congenital hypoprothrombinemia and dysprothrombinemia.
Haemostasis. 1982;12(4):309-16. doi: 10.1159/000214689.
8
Hypoprothrombinemia and severe hemorrhage associated with a lupus anticoagulant.低凝血酶原血症及与狼疮抗凝物相关的严重出血。
J Pediatr. 1993 Dec;123(6):937-9. doi: 10.1016/s0022-3476(05)80390-7.
9
Development of factor V and thrombin inhibitors in children following bovine thrombin exposure during cardiac surgery: a report of three cases.心脏手术期间接触牛凝血酶后儿童中因子V和凝血酶抑制剂的发生：三例报告
Congenit Heart Dis. 2010 May-Jun;5(3):303-8. doi: 10.1111/j.1747-0803.2009.00344.x.
10
A rat liver protein with potential thrombin activity: properties and partial purification.一种具有潜在凝血酶活性的大鼠肝脏蛋白：特性与部分纯化
Arch Biochem Biophys. 1973 Nov;159(1):483-91. doi: 10.1016/0003-9861(73)90478-5.

本文引用的文献

1
Significantly prolonged PT and APTT could indicate a wide spectrum of clinical manifestations in three patients with plasma cell disorders.显著延长的凝血酶原时间（PT）和活化部分凝血活酶时间（APTT）可能提示三名浆细胞疾病患者存在广泛的临床表现。
Int J Lab Hematol. 2019 Feb;41(1):e23-e26. doi: 10.1111/ijlh.12936. Epub 2018 Oct 19.
2
New tests to detect antiphospholipid antibodies: antiprothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies.新的抗磷脂抗体检测试验：抗凝血酶原 (aPT) 和抗磷脂酰丝氨酸/凝血酶原 (aPS/PT) 抗体。
Curr Rheumatol Rep. 2014 May;16(5):415. doi: 10.1007/s11926-014-0415-x.
3
Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review.
抗凝血酶原 (aPT) 和抗磷脂酰丝氨酸/凝血酶原 (aPS/PT) 抗体与抗磷脂综合征中的血栓形成风险。系统评价。
Thromb Haemost. 2014 Feb;111(2):354-64. doi: 10.1160/TH13-06-0509. Epub 2013 Oct 31.
4
Bleeding and thrombosis in multiple myeloma and related plasma cell disorders.多发性骨髓瘤及相关浆细胞疾病中的出血与血栓。
Semin Thromb Hemost. 2011 Nov;37(8):929-45. doi: 10.1055/s-0031-1297372. Epub 2011 Dec 23.
5
Pathogenesis and management of bleeding and thrombosis in plasma cell dyscrasias.浆细胞异常增殖性疾病中出血与血栓形成的发病机制及管理
Br J Haematol. 2009 Apr;145(2):151-63. doi: 10.1111/j.1365-2141.2008.07577.x. Epub 2009 Feb 4.
6
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).关于明确抗磷脂综合征（APS）分类标准更新的国际共识声明。
J Thromb Haemost. 2006 Feb;4(2):295-306. doi: 10.1111/j.1538-7836.2006.01753.x.
7
Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus.在两种不同检测系统中检测到抗凝血酶原抗体。系统性红斑狼疮中的患病率及临床意义。
Thromb Haemost. 2005 Feb;93(2):289-97. doi: 10.1160/TH04-06-0382.
8
A plasma coagulation defect in systemic lupus erythematosus arising from hypoprothrombinemia combined with antiprothrombinase activity.系统性红斑狼疮中因低凝血酶原血症合并抗凝血酶原酶活性而产生的血浆凝血缺陷。
Blood. 1960 Feb;15:212-27.
9
Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.抗磷脂酰丝氨酸-凝血酶原复合物自身抗体与抗磷脂综合征表现及狼疮抗凝物存在情况的关联。
Arthritis Rheum. 2000 Sep;43(9):1982-93. doi: 10.1002/1529-0131(200009)43:9<1982::AID-ANR9>3.0.CO;2-2.
10
Identification of a monoclonal thrombin inhibitor associated with multiple myeloma and a severe bleeding disorder.
Br J Haematol. 1997 Apr;97(1):219-26. doi: 10.1046/j.1365-2141.1997.d01-2145.x.